Amyotrophic Lateral Sclerosis Treatment Market Expected to Reach USD 0.97 Billion by 2030 at a CAGR of 5.1% | MarkNtel

A Quick Overview of Amyotrophic Lateral Sclerosis Treatment Market

• Base Year: 2024

• Historical Years: 2020-2023

• Forecast Years: 2025-2030

• Market Growth Rate: 5.1% (2025-2030)

The key object of this report on the Amyotrophic Lateral Sclerosis Treatment Market is to offer worthy data and a geographical perspective for predictions of market growth in the future. The recommendations added in this detailed report are insightful, and actionable offering a deep understanding of the industry. Moreover, it includes a comprehensive importance of aspects that have impacted the industry.

MarkNtel Advisors has recently studied an extensive market intelligence evaluation on the market. Also, the newly released report exhibits an engaging format that comprises compelling graphs, tables, charts, and figures as well. These seamlessly combined visual aids are designed to support the clarity and accuracy of the details presented, offering analysts a deep knowledge of the topic at hand.

According to the latest report, the Global Amyotrophic Lateral Sclerosis Treatment Market size was valued at around USD 0.72 billion in 2024 and is projected to reach USD 0.97 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 5.1% from 2025 to 2030. The report significantly addressed considerable changes, gap analyses, and competitive studies using qualitative and quantitative data.

Request Sample Report or Discuss More - https://www.marknteladvisors.com/query/request-sample/amyotrophic-lateral-sclerosis-treatment-market.html

Market Dynamics:

Driver-

Growing Prevalence of Amyotrophic Lateral Sclerosis - The rising cases of amyotrophic lateral sclerosis worldwide are one of the main factors that drive the market for this neurodegenerative condition. The disease is majorly growing in the North American region more likely to affect Whites and non-Hispanics. It is anticipated that the prevalence of amyotrophic lateral sclerosis will slightly increase as a result of the aging population, early diagnosis, and greater global awareness. Approximately 5,000 cases of amyotrophic lateral sclerosis are diagnosed every year in the US.

Although it is a rare disease still the global prevalence rate of ALS is around 4-6 cases per 100,000 individuals. Furthermore, males have a higher prevalence than females comparatively but in old age, they are equally likely to be diagnosed with ALS. Sporadic ALS is making up to 90-95% of the total cases globally. Thus, the prevalence of ALS will continue to drive market growth during the forecast period.

Amyotrophic Lateral Sclerosis Treatment Market Report Segmentation:

The report by MarkNtel Advisors on Amyotrophic Lateral Sclerosis Treatment Industry, analyzes, identifies, and highlights the main trends and drivers which are affecting each segment of the market. The market has been further divided into the following categories:

By Disease Type

• Sporadic ALS

• Familial ALS

By Treatment

• Medication

•• Riluzole

•• Edaravone

•• Nuedexta

•• Others

• Stem Cell Therapy

• Others

By Distribution Channel

• Hospital Pharmacies

• Retail Pharmacies

• Others

- Out of them, hospital pharmacies lead the Global Amyotrophic Lateral Sclerosis Treatment Market. They hold approximately 58.4% share of the total market value. The complex and multidisciplinary treatment needs of ALS patients frequently need specialized care, continuous hospital stays, and a need for an easily accessible supply of ALS medications. Hospital pharmacies dominate this market because they offer a central location for patients who require close medical supervision and convenient access to necessary medications.

By Route of Administration

• Oral

• Parenteral-Market Size & Forecast 2020-2030, USD Million

By End User

• Hospitals

• Rehabilitation Centers

• Specialty Clinics-Market Size & Forecast 2020-2030, USD Million

• Others

By Region

• North America

• South America

• Europe

• The Middle East & Africa

• Asia-Pacific

Access the Complete Report for An In-Depth Analysis - https://www.marknteladvisors.com/research-library/amyotrophic-lateral-sclerosis-treatment-market.html

Some of the Top Amyotrophic Lateral Sclerosis Treatment Companies in the Market

In the fast-changing Amyotrophic Lateral Sclerosis Treatment Market, understanding what our competitors are doing is crucial. By carefully analyzing things, we figured out some of the dominating players in the industry. So, the top players of the industry ruling the industry are:

• Mitsubishi Tanabe Pharma Corporation (Mitsubishi Chemical Group Corporation)

• Biogen

• BrainStorm Cell Limited

• Amylyx Pharmaceuticals, Inc.

• Ionis Pharmaceuticals, Inc.

• Sanofi

• Otsuka Pharmaceutical Co., Ltd.

• F. Hoffmann-La Roche Ltd.

• AB Science

• Sun Pharmaceutical Industries Ltd.

• Orion Corporation

• CORESTEMCHEMON Inc.

• Others

Need additional assistance?

• Looking for more assistance? Connect with our experienced analysts for insights into current market trends.

• Customize your report by adding specific segments and countries to meet your needs. Gain a significant competitive edge by learning how to leverage these insights to enhance your operations and boost revenue.

• For further support, don't hesitate to reach out to our analysts.

*Reports Delivery Format - Market research studies from MarkNtel Advisors are offered in PDF, Excel, and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address

Other Report:

• https://dutchmanresearch.blogspot.com/2024/12/africa-tire-market-key-competitors-who.html

• https://dutchmanresearch.blogspot.com/2024/12/france-agrivoltaic-market-overview.html

• https://dutchmanresearch.blogspot.com/2024/12/substantial-growth-projected-for-gcc_5.html

For Media Inquiries, Please Contact:

Phone: +1 628 895 8081 | +91 120 4278433

Email: sales@marknteladvisors.com

Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511

Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India

About US:

MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.

We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.

This release was published on openPR.